Goldman Sachs Group Inc Pacific Biosciences Of California, Inc. Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 484,741 shares of PACB stock, worth $853,144. This represents 0.0% of its overall portfolio holdings.
Number of Shares
484,741
Previous 1,864,483
74.0%
Holding current value
$853,144
Previous $2.2 Million
72.68%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding PACB
# of Institutions
245Shares Held
202MCall Options Held
879KPut Options Held
847K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl36.3MShares$63.9 Million0.37% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$41.6 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M020.5MShares$36 Million0.11% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA16.8MShares$29.5 Million2.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$28.2 Million0.0% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $396M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...